Manufacturing & Packaging

Agreement allows CRO to grow its manufacturing services, including in the chemistry space

Marks the first step in two-phase facility expansion project

Center’s 89,000 square-foot expansion expected to double its capacity

Strategic collaboration will feature Mammoth’s CRISPR know-how to design in vivo therapies

Collaboration aims to prioritize best practices in fields of biopreservation and closed-system manufacturing, while improving children’s health

The shot—which could be the first one to be mRNA based—is scheduled to begin clinical trials later this year

Investment features the construction of a high-throughput screening center

BFS technology deal expected to be finalized in Q1

ABC’s new acquisition, FirstView Financial, addresses underpayment of pharmacies, as well as patient assistance programs

Pharma firms—not only in Europe but in the US as well—are continuously looking for alternative supply channels inside their respective blocks

The $17.4-billion deal, CDMO says, will help expand its offerings in the clinical development space

Site is located in the state of Gujarat, a major hub for pharma logistics

CDMO’s financial commitment will feature construction of a new GMP clinical trial development facility

Financial commitment is predicted to more than double the biopharma site’s manufacturing capabilities

Transaction expands CDMO’s services, including more solutions surrounding commercial manufacturing

Five-year deal covers manufacturing of molecules, ranging from monoclonal antibodies to antibody-drug conjugates

Subject to regulatory approval, CDMO will produce mRNA vaccine on a commercial scale

Opens a ‘Cold Chain Packaging Center of Excellence’ in Kentucky, while expanding services globally

It’s not just innovator pharma companies concerned with the proposed compromise to Medicare price negotiations and inflation-based rebates

CDMO’s expansion of Hopkinton, MA facility will include seven new ISO 7 cGMP suites

Deal expected to boost firm’s offerings via FDS's delivery system services

Anticipated capacity of GMP facility is 60 million vials per year

Additional equipment to be added to the plant next year

Development project features additional manufacturing suites, expansion of storage capabilities

mRNA jab maker plans to initially produce 50 million Covid vaccine doses per year